Work Here?
Industries
Industrial & Manufacturing
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Debt Financing
Total Funding
$700K
Headquarters
Chesterfield, Missouri
Founded
2014
Grenova Solutions focuses on sustainability and cost reduction in laboratories, particularly by minimizing the use of plastic consumables like pipette tips, which contribute significantly to biohazard waste. Their patented products and processes enable laboratories to cut plastic waste by up to 90%, resulting in substantial cost savings that can be redirected towards research and operational improvements. Grenova serves a diverse clientele in the life sciences sector, including research institutions, pharmaceutical companies, and clinical laboratories, helping them achieve their environmental goals while enhancing profitability. Unlike competitors, Grenova combines the sale of its patented devices with ongoing support and maintenance services, creating a comprehensive sustainability model. The company's goal is to lead the lab industry towards more sustainable practices while supporting its clients in reducing their environmental footprint.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$700k
Below
Industry Average
Funded Over
2 Rounds
Grenova, a Virginia-based sustainable lab tech firm, announced the appointment of Ted Hull to its board and the completion of a new growth equity round. Hull, with 30+ years in life sciences, will guide Grenova's strategic direction. The funding, led by Peloton Equity and Hamilton Lane's Impact Fund II, will enhance automation, R&D, and team expansion. CEO Katherine Marrs highlighted the investment's role in reducing plastic waste and scaling sustainable lab practices.
In late 2022, Civica announced a nearly $125 million investment to build a 120,000 square-foot sterile manufacturing facility and create more than 180 jobs.
Richmond life sciences laboratory product company Grenova has appointed Richard Pellegrino as its chief research and development officer.
Grenova, a manufacturer of instruments and associated consumables for the life sciences industry, announced the appointment of Katherine Marrs as chief commercial officer.
RICHMOND, Va., April 12, 2023 /PRNewswire/ -- Grenova, Inc., a Virginia-based designer, manufacturer, and distributor of instruments and associated consumables for the life sciences industry, today announced the appointment of Lane Major as President and Chief Executive Officer, and as a member of Grenova's Board of Directors. Most recently, Major served as Vice President and General Manager of Stryker Spine, building and integrating ~$2 billion in investment around medical device and enabling technologies across more than 40 countries.Lane Major, President and Chief Executive Officer at Grenova.Major holds more than 20 years of experience as an entrepreneur, executive, and board member in the medical and life sciences product industry. In 2004, he co-founded K2M, Inc. ("K2M"), a supplier of medical device solutions for complex spine and minimally invasive procedures. Major served in numerous roles during his tenure at K2M, including as Chief Operating Officer and Chief Strategy Officer. During that time, he helped lead the company from $0 to $300 million in revenue, as well as a private equity exit, a 2014 IPO, and K2M's $1.4 billion acquisition by Stryker Corp in 2018
Find jobs on Simplify and start your career today
Discover companies similar to Grenova
Industries
Industrial & Manufacturing
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Debt Financing
Total Funding
$700K
Headquarters
Chesterfield, Missouri
Founded
2014
Find jobs on Simplify and start your career today
Discover companies similar to Grenova